Blog

Blog Posts in November, 2012

Blog Home
  • New Whistleblower Law

    Posted By Regan Zambri & Long || 29-Nov-2012

    Posted by: Salvatore J. Zambri, founding member and partner I have represented whistleblowers for many years. A "whistleblower" is someone who reports fraud perpetrated against the government, typically by the company for whom the whistleblower works. It takes courage to report fraud by an employer, but it is this very courage that is needed to hold companies accountable for their ...
    Continue Reading
  • Anticlotting Drug Pradaxa Allegedly Causing Deaths

    Posted By Regan Zambri & Long || 5-Nov-2012

    Posted by: Salvatore J. Zambri, founding member and partner Please read the front-page of the Business Day section of the New York Times (11/3, B1, Thomas, Subscription Publication, 1.23M), which reported that blockbuster anticlotting drug Pradaxa is producing deaths from unstoppable bleeding, and critics are taking aim at the FDA "because it allowed a potentially dangerous drug to be sold ...
    Continue Reading
  • Merck to Settle Rofecoxib Class-Action Suit

    Posted By Regan Zambri & Long || 5-Nov-2012

    Posted by: Salvatore J. Zambri, founding member and partner The AP (11/2) reported Merck & Co. Inc. announced Nov. 1 that it has "agreed to settle a class action lawsuit filed on behalf of Missouri consumers" over its prescription painkiller Vioxx (rofecoxib). The FDA "approved Vioxx as a painkiller in May 1999," but the Justice Department "said Merck began marketing ...
    Continue Reading
  • 3 results found. Viewing page 1 of 1.